Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

'Lame Duck' Congress Has High Stakes For Pharma Companies

Nov 29 2018

• By Michael McCaughan

Ducks follow me, cute ducklings (duck babies) following mother in a queue,lake,symbolic figurative harmonic peaceful animal family portrait following team grouping together group trust safety harmony — Can legislators get their ducks in a row to complete pharma legislation?

Related Content

Biodefense Bill Moving In Senate; Still Debate Over Best Approach For Flu

Jun 04 2018

Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions

Jun 04 2018

Democrat-Controlled House Will Turn Up The Volume On Drug Pricing

Nov 07 2018

The Budget Blindside: Did Pharma Fight The Wrong Battle?

Feb 21 2018

Additional Topics

United States OTC Drugs FDA Legislation Elections Reimbursement Policy Market Access BioPharmaceutical Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window